BioSpace News Archive

Brandicourt, who has helmed Sanofi since 2015, will retire from his CEO role this fall. Sanofi has a rule that its CEO cannot be over the age of 65.

The fixed-dose combination was being evaluated in adults with intermediate and high-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.

In addition to the deals, Vertex announced a new genetic therapies research site in the Boston and a new head of genetic therapies.

Phase II data showed the triple combination treatment provided 16 months of progression-free survival of patients.

The guidance tends to focus on getting sponsor companies to include more historically underserved populations in clinical trials, including women, the elderly and minorities.

There has been a spate of recent news regarding the expansion of facilities and the expected job growth for the biopharma and life sciences industry. Here’s a look at some of those stories.

Researchers with the Salk Institute found that in mice, at least, the brain, liver and pancreas have cells that are young and extremely old. In tissues and cell lines, when there is a mix, it is called “mosaicism.” They have dubbed this phenomenon “age mosaicism.”

Here’s a look at some of last week’s clinical trial announcements, including some from the American Society of Clinical Oncology Annual Meeting you might have missed.

California is well-known for its position in the biotech and pharma industry, with two world-class hubs in the Bay Area and the San Diego region. However, a new survey reveals the state is actually home to three significant hubs.

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that following 10 consecutive business days with a market value of listed securities (“MVLS”) of over US$35 million, the Company has been advised by staff of The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq will exercise its discretion to continue to monitor the Company’s MVLS pursuant to Nasdaq Listing Rule 5810